share_log
Reuters ·  May 9 07:11
Mineralys Therapeutics Inc - Ongoing Explore-Ckd Phase 2 Trial Is Anticipated to Deliver Topline Data in Q4 2024 to Q1 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment